Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSEN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD300LB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHRNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928580 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL36A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEMK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD84 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC22C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF683 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on